HomeAPPH • ETR
add
Apontis Pharma AG
Previous close
€10.80
Day range
€10.80 - €10.80
Year range
€6.30 - €12.35
Market cap
92.24M EUR
Avg Volume
916.00
P/E ratio
140.26
Dividend yield
-
Primary exchange
ETR
Market news
Financials
Income Statement
Revenue
Net income
| (EUR) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | 13.02M | 14.55% |
Operating expense | 7.75M | 20.29% |
Net income | 301.88K | -14.09% |
Net profit margin | 2.32 | -24.92% |
Earnings per share | — | — |
EBITDA | 743.21K | -30.45% |
Effective tax rate | 23.26% | — |
Balance Sheet
Total assets
Total liabilities
| (EUR) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 11.38M | -29.58% |
Total assets | 43.99M | -8.75% |
Total liabilities | 12.37M | -28.26% |
Total equity | 31.62M | — |
Shares outstanding | 8.33M | — |
Price to book | 2.84 | — |
Return on assets | 2.21% | — |
Return on capital | 3.07% | — |
Cash Flow
Net change in cash
| (EUR) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | 301.88K | -14.09% |
Cash from operations | -976.23K | 49.64% |
Cash from investing | -1.06M | -224.21% |
Cash from financing | — | — |
Net change in cash | -2.04M | 61.75% |
Free cash flow | -464.93K | -187.91% |
About
Founded
1946
Website
Employees
137
